Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

ional information about GenVec is available at www.genvec.com and in the Company's various filings with the Securities and Exchange Commission.

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding funding, grants, collaborations, revenues, cash burn rates, the development of products and the success of the Company's collaborations, including with Novartis and Merial, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act.  GenVec cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by GenVec to secure and maintain relationships with collaborators; risks relating to the early stage of GenVec's product candidates under development; uncertainties relating to research and development activities; risks relating to the commercialization, if any, of GenVec's proposed product candidates; dependence on the efforts of collaborators and third parties; dependence on intellectual property; currently unanticipated expenses, and risks that we may lack the financial resources and access to capital to fund our operations.  Further information on the factors and risks that could affect GenVec's business, financial conditions and results of operations, are contained in GenVec's filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov.  These forward-looking statements speak only as of the date of this press release, and GenVec assumes no duty to update forward-looking statements.

(Tables to follow)GenVec
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Research and Markets  has announced the addition ... 2014-2017" report to their offering. ... protein drug market has been expanding rapidly owing to ... like. During 2005-2013, sales of recombinant protein drugs available ... 19.1%, and it is projected that ...
(Date:11/21/2014)... DIEGO , Nov. 21, 2014  Tandem ... TNDM ), a medical device company and manufacturer ... announced a partnership with Tidepool, a non-profit dedicated ... open source software platform that increases diabetes data ... Tidepool Platform, which is currently under development, to ...
(Date:11/21/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... to acquire 100% of QCR & Trio Diagnostics Limited, ... organization. The transaction closed on November 17, 2014. ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... N.J., April 23, 2012  Veridex, LLC announced today ... in an educational alliance to encourage and facilitate ... a potential biomarker in metastatic prostate cancer. ... support a prospective, single arm, open-label study designed ...
... 23, 2012 Qmed .com , ... supplier directory, search engine, and central industry ... only site that provides ground-breaking detailed reports of ...   (Logo: http://photos.prnewswire.com/prnh/20120423/LA91769LOGO )   ...
Cached Medicine Technology:New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer 2New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer 3New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer 4Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 2Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 3Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events 4
(Date:11/22/2014)... 22, 2014 “Due to my knee replacement ... from Gurnee, Ill. “While using the ice grip attachment, I ... thought there needed to be a safer way to prevent ... BLOCK. , The SPIKE BLOCK offers added safety and stability ... help to reduce injuries and damage associated with traditional spiked ...
(Date:11/22/2014)... order to provide better services, LunaDress has updated its website ... knows that a suitable cocktail party dress is crucial for ... party dresses supplier’s high quality items are offered at attracting ... fashion industry, LunaDress understands that it is not easy to ... raises the professional level and innovation ability. The growth of ...
(Date:11/22/2014)... "My friend went in for a mammogram ... said an inventor from Cambria Heights, N.Y. "To add ... second time because the first results were inaccurate. Her ... patent-pending MAMO EASY to offer a more comfortable way ... patient from the pain normally involved with this procedure. ...
(Date:11/22/2014)... Domestic farmgate milk and dairy solids ... to a fall in demand for Butter ... the global financial crisis. However, these declines did ... manufacturers on the international scene. Strong growth in ... primarily due to supply constraints in some key ...
(Date:11/22/2014)... November 22, 2014 The topic of ... of block retaining walls. The article states that, “While they ... several necessary steps that go into creating this powerful look.” ... a retaining wall is choosing which kind of block matches ... , B&D Rockeries says, “The two main options are concrete ...
Breaking Medicine News(10 mins):Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2
... had a ,protective, effect , , TUESDAY, Oct. 30 (HealthDay ... depression finds that their risk factors for suicide differ ... , Specifically, the risk for suicide appears highest among ... the general population. , And even though post-traumatic stress ...
... Roper Industries,Inc. (NYSE: ROP ) announced that ... on Tuesday, November 6, 2007 at 1:20 PM (Central,Time), ... of the presentation,will be available in the "Investor Information" ... About Roper Industries Roper Industries is a market-driven, ...
... Calif., Oct. 30 West Anaheim Medical,Center, ... (PHS), has,installed a state-of-the-art patient tracking and ... within the hospital,s MEDITECH,system, the application is ... assist providers in managing their Emergency Department,patients ...
... knowledge of basic vision care, safety, survey finds , , ... half of all American adults say eyesight is their ... says an American Optometric Association (AOA) survey released Monday. ... years or older found that Americans lack awareness in ...
... Wellness Destination, The HealthCentral,Network, Recognized by the ... ARLINGTON, Va., Oct. 30 The ... from the,International Academy of the Visual Arts ... The W3 Awards, which honors creative,excellence on ...
... Oct 30 Perrigo Company,(Nasdaq: PRGO ; TASE) ... dividend of $0.05 per share, payable on December 18, ... new quarterly dividend of,$0.05 per share represents an eleven ... four quarters. Perrigo Company is a leading global ...
Cached Medicine News:Health News:Younger Veterans at Greater Suicide Risk 2Health News:Younger Veterans at Greater Suicide Risk 3Health News:Younger Veterans at Greater Suicide Risk 4Health News:Hospital Launches State-of-the-Art Patient Tracking and Integrated Patient Data System 2Health News:Most Americans Have Poor 'Eye-Q' 2Health News:The HealthCentral Network Wins W3 Award for Breast Cancer Web Site 2
PoleStar N-10 is a compact MRI unit that does not require a specially constructed surgery suite. The magnetic field is confined to the volume between the magnet poles and it's immediate neighborhood....
... Surgical Adhesive (Bioglue) is a two-component ... serum albumin (BSA) and glutaraldehyde. The ... from bovine spongiform encephalopathy (BSE) free ... or inactivates viruses. The solutions are ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: